Chen, Axt Inc director, sells $700k in AXTI stock

Director Jesse Chen sold 14,086 shares of AXT Inc (AXTI) on Mar 12-13 for approximately $700,039, retaining 109,526 shares. AXT cut Q4 revenue guidance to $22.5M–$23.5M from $27M–$30M, citing reduced export permits for indium phosphide from China’s Ministry of Commerce. The stock trades near its 52-week high of $51.98 after a 2,614% one-year return; Craig-Hallum raised its price target to $26 (Buy) while B. Riley downgraded to Neutral but lifted its target to $18, leaving investor outlook mixed.

Analysis

China’s selective tightening of export permits for indium phosphide is the most actionable supply-shock in this note — it creates a multi-quarter capacity squeeze for InP-dependent fabs that can meaningfully reorder equipment demand curves. Firms that either hold alternative wafer/epi sources, inventories, or differentiated process technologies (metrology and subfab suppliers) should see order acceleration and pricing power over the next 6–18 months, while small-cap pure-play component producers that rely on spot exports face volatile revenue recognition and backlogs.

AXT’s guidance cut plus insider selling amplifies short-term downside risk in its stock despite robust trailing returns; a near-term revenue miss signal typically compresses small-cap semi-equipment multiples by 20–35% within 3 months when visibility drops. Conversely, NVMI and Ichor are positioned to capture reallocated spend: NVMI benefits from increased metrology intensity at memory fabs (higher attach rates per wafer) and ICHR from elevated demand for power-supply/gas-delivery modules that scale with wafer starts — these are 6–18 month structural upside plays tied to capex cadence, not near-term spot gyrations.

Macro and policy tails matter: a reopening of Chinese export permits, sudden destocking by OEMs, or global capex pullback could undo the scarcity premium quickly (weeks–quarters). Watch orderbook-to-revenue conversion (bookings / TTM revenue) and ship-week cadence as the lead indicators; a sustained >1.2x bookings ratio over two quarters is the earliest signal of durable demand reallocation and justifies adding convex exposure.

Key Decisions for Investors

• Pair trade (6–12 months): Long NVMI equity or 9–12 month call LEAP (target +60–120%) / Short AXTI via 3–6 month put spread (sell $45 put, buy $35 put or equivalent) to cap risk. Rationale: capture secular metrology re-rate while hedging semiconductor equipment beta. Position size: 1–2% NAV net delta; stop-loss: NVMI -30% / AXTI short loss > 25% of premium.
• Directional short AXTI (3–6 months): Initiate a tactical short or buy-to-open 3–6 month $50–$60 put spread sized to 0.5–1% NAV with a target return 2–3x premium (~30–60% absolute). Catalysts: further revisions to guidance, visible order cancellations, or insider follow-through selling.
• Opportunistic long ICHR (12 months): Buy shares or 12-month calls to play derivative exposure to Lam/AMAT capex cadence. Target +30–50% if memory/logic capex sustains; risk: macro capex pullback—use 25% trailing stop or reduce to 0.5–1% NAV.
• Risk control & alerts: Set automated alerts on (a) China export permit announcements, (b) NVMI bookings/ops updates, and (c) AXTI weekly ship/PO trends. If bookings/ship-rate for NVMI or ICHR rise >15% QoQ, add to positions; if Chinese permit flow normalizes (permits restored to pre-shock levels within 60 days), reduce scarcity-biased longs by 40–60%.